GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gujarat Themis Biosyn Ltd (BOM:506879) » Definitions » Price-to-Owner-Earnings

Gujarat Themis Biosyn (BOM:506879) Price-to-Owner-Earnings : 63.23 (As of May. 31, 2025)


View and export this data going back to 2001. Start your Free Trial

What is Gujarat Themis Biosyn Price-to-Owner-Earnings?

As of today (2025-05-31), Gujarat Themis Biosyn's share price is ₹307.95. Gujarat Themis Biosyn's Owner Earnings per Share (TTM) ended in Mar. 2025 was ₹4.87. It's Price-to-Owner-Earnings for today is 63.23.


The historical rank and industry rank for Gujarat Themis Biosyn's Price-to-Owner-Earnings or its related term are showing as below:

BOM:506879' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 11.49   Med: 29.78   Max: 98.33
Current: 64.15

During the past 13 years, the highest Price-to-Owner-Earnings of Gujarat Themis Biosyn was 98.33. The lowest was 11.49. And the median was 29.78.


BOM:506879's Price-to-Owner-Earnings is ranked worse than
82.1% of 447 companies
in the Drug Manufacturers industry
Industry Median: 25.25 vs BOM:506879: 64.15

As of today (2025-05-31), Gujarat Themis Biosyn's share price is ₹307.95. Gujarat Themis Biosyn's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹4.48. Therefore, Gujarat Themis Biosyn's PE Ratio (TTM) for today is 68.69.

As of today (2025-05-31), Gujarat Themis Biosyn's share price is ₹307.95. Gujarat Themis Biosyn's EPS without NRI for the trailing twelve months (TTM) ended in was ₹4.48. Therefore, Gujarat Themis Biosyn's PE Ratio without NRI for today is 68.69.

During the past 13 years, Gujarat Themis Biosyn's highest PE Ratio without NRI was 76.37. The lowest was 5.14. And the median was 16.98.


Gujarat Themis Biosyn Price-to-Owner-Earnings Historical Data

The historical data trend for Gujarat Themis Biosyn's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gujarat Themis Biosyn Price-to-Owner-Earnings Chart

Gujarat Themis Biosyn Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.08 16.03 25.53 55.63 57.80

Gujarat Themis Biosyn Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 55.63 - - - 57.80

Competitive Comparison of Gujarat Themis Biosyn's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Gujarat Themis Biosyn's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gujarat Themis Biosyn's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gujarat Themis Biosyn's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Gujarat Themis Biosyn's Price-to-Owner-Earnings falls into.


;
;

Gujarat Themis Biosyn Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Gujarat Themis Biosyn's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=307.95/4.87
=63.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gujarat Themis Biosyn  (BOM:506879) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Gujarat Themis Biosyn Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Gujarat Themis Biosyn's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Gujarat Themis Biosyn Business Description

Traded in Other Exchanges
Address
S.V Road, Themis House, 11/12 Udyog Nagar, Goregaon (West), Mumbai, MH, IND, 400104
Gujarat Themis Biosyn Ltd is engaged in manufacturing, exporting, and selling of bulk drugs on a job-work basis. The company operates in one segment which is pharmaceuticals. Its products include Rifamycin-S, which is an intermediate for Rifampicin for the treatment of tuberculosis (TB), and Lovastatin.

Gujarat Themis Biosyn Headlines

No Headlines